Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

HFE

Image courtesy of "The Silver Sheet"

Image courtesy of "The Silver Sheet"

Human Factors Engineering

HFE applies what is known about human limitations and capabilities to the design of products or systems. By incorporating HFE into the development process, the resulting product should be more intuitive and easier to use, resulting in improved compliance and minimizing use related hazards.

More and more medicines are intended for administration without the intermediation of a healthcare professional. The FDA has expressed alarm at the number of reports of medical device errors outside the clinical setting (more than 19,000 from 1997 to 2009). As Ron Kaye, the FDA lead on Human Factors and Devices said, “The reality is dawning on everyone that this stuff is important and it needs a lot of work.”

HFE has been central to Intelliject’s development approach from the very beginning. Intelliject is represented on national and international expert groups on this topic – including Human Factors & Ergonomics Society (HFES) and the Medical Devices for Injection and Human Factors Committees for the Association of the Advancement of Medical Instrumentation (AAMI) – our goal is to set the standard on incorporating HFE into product development. Our development process involves multiple iterations with patients and other users ensuring that every aspect of the final product has been evaluated through the lens of the user.

Why Now?

More than 100 US medicines' patents expired in 2009 Read More

Clinical & Cost Data

Intelliject studies generate head-to-head data versus the current Standard of Care. View our Clinical & Cost Data

Key patent expiries by 2012:

Zyprexa, Plavix, Seroquel, Lipitor Why Now?

Anaphylaxis Solution Video

To see a video demonstrating how Intelliject's product could theoretically be used in anaphylactic emergency, click here

Loss of Patent Protection

Of the 20 biggest drugs in the world, 18 will lose patent protection in the next five years. Why Now?

Hypoglycemia Solution Video

To see a video demonstrating how Intelliject's product could theoretically be used in hypoglycemic emergency, click here

Why Now?

$1.3 billion to bring a new drug to market in 2009.Read More

Solutions

Intelliject's pipeline targets a number of areas requiring self/caregiver administered injections.Read More

Why Now?

2009-2014: Injectable drug sales will increase by $42 billion. Read More

Patient-Centric

Human Factors Engineering (HFE) is central to ensuring that Intelliject's products are patient-centric Learn More

THIS WEBSITE IS NOT INTENDED FOR PATIENTS OR HEALTHCARE PROFESSIONALS. Members of the public, patients and healthcare professionals should not enter this website. If you are a patient, please see your healthcare professional for more information. This website is intended solely for entities that are current or potential business partners of Intelliject, Inc. Intelliject currently has NO FDA APPROVED PRODUCTS and nothing herein is a promotional therapeutic claim.

All information contained herein is intended to assist interested parties in assessing possible business relationships with Intelliject, Inc. All information is believed to be correct at the date of posting but may change at any time.

I have read the statements above. I am an interested party assessing possible business relationships with Intelliject, Inc.